US Patent Litigations are now available. Check here

Explore H Lundbeck's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 17, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2608789Aug 21, 2024Therapeutic Uses Of 1-[2-(2,4-Dimethyl-Phenylsulfanyl)Phenyl]Piperazine1
EP3345604Jun 7, 2023Nalmefene For Reduction Of Alcohol Consumption In Specific Target Populations2
EP3615518Dec 15, 2021Process For The Manufacture Of Vortioxetine Hbr Alpha-Form1
EP3138564Jan 31, 2018Nalmefene For Reduction Of Alcohol Consumption In Specific Target Populations1